Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors

2011 ◽  
Vol 32 (8) ◽  
pp. 731-737 ◽  
Author(s):  
Marcel P.M. Stokkel ◽  
Daphne D. Rietbergen ◽  
Catharina M. Korse ◽  
Babs G. Taal
Keyword(s):  
Neuroendocrine Tumors ◽  
Chromogranin A ◽  
Somatostatin Receptor ◽  
Somatostatin Receptor Scintigraphy ◽  
Receptor Scintigraphy ◽  
Well Differentiated

scholarly journals Validation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine Tumors

1993 ◽  
Vol 32 (2) ◽  
pp. 167-170 ◽  
Author(s):  
Steven W. J. Lamberts ◽  
Jean-Claude Reubi ◽  
Eric P. Krenning
Keyword(s):  
Neuroendocrine Tumors ◽  
Somatostatin Receptor ◽  
Somatostatin Receptor Scintigraphy ◽  
Receptor Scintigraphy

scholarly journals 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

2007 ◽  
Vol 48 (4) ◽  
pp. 508-518 ◽  
Author(s):  
M. Gabriel ◽  
C. Decristoforo ◽  
D. Kendler ◽  
G. Dobrozemsky ◽  
D. Heute ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Somatostatin Receptor ◽  
Somatostatin Receptor Scintigraphy ◽  
Receptor Scintigraphy

scholarly journals Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix

2020 ◽  
Vol 8 (17) ◽  
pp. 3697-3707
Author(s):  
Jelena Saponjski ◽  
Djuro Macut ◽  
Dragana Sobic-Saranovic ◽  
Sanja Ognjanovic ◽  
Ivana Bozic Antic ◽  
...  
Keyword(s):  
Somatostatin Receptor ◽  
Somatostatin Receptor Scintigraphy ◽  
Neuroendocrine Neoplasms ◽  
Receptor Scintigraphy

Bone Lesion in a Patient with Transplanted Liver for a Metastatic Carcinoid. The Role of Somatostatin Receptor Scintigraphy

1998 ◽  
Vol 84 (1) ◽  
pp. 82-84 ◽  
Author(s):  
Giordano Savelli ◽  
Arturo Chiti ◽  
Antonella Spinelli ◽  
Enrico Regalia ◽  
Vincenzo Mazzaferro ◽  
...  
Keyword(s):  
Imaging Techniques ◽  
Somatostatin Receptor ◽  
Bone Lesion ◽  
Somatostatin Receptor Scintigraphy ◽  
Resonance Imaging ◽  
Metastatic Carcinoid ◽  
Ultrasound Computed Tomography ◽  
Receptor Scintigraphy

A patient who had previously undergone ileal resection and liver transplantation for a gastroenteropancreatic (GEP) tumor was evaluated with somatostatin receptor scintigraphy (SRS) using 111In-DTPA-D-Phe1-pentetreotide. Eighteen months after surgery, during follow-up procedures, conventional imaging techniques (ultrasound, computed tomography, magnetic resonance imaging) only showed a relapse in the gastropancre-atic lymph nodes, while SRS demonstrated skeletal spread. This case report emphasizes the clinical impact of SRS on the management of patients affected by neuroendocrine gastroenteropancreatic tumors.

Sign in / Sign up

Export Citation Format

Share Document